Jakob Dal

Jakob Dal is an Associate Professor at Aalborg University's Faculty of Health Sciences and a Senior Consultant at Aalborg University Hospital's Department of Endocrinology. His dual role bridges clinical practice and academic research in endocrinology, with particular expertise in pituitary disorders and transgender healthcare.

Dr. Dal's research spans a wide spectrum of endocrine conditions, with special emphasis on acromegaly, prolactinomas, and hypothalamic obesity. His methodological approach includes registry-based research, epidemiology, biomarker studies, genetics, and clinical intervention studies. He has considerable experience with both mono- and multi-center projects, Delphi processes, and patient involvement initiatives.

Analysis of his recent publications reveals a strong focus on acromegaly epidemiology and management, transgender healthcare outcomes, and diabetes-related quality of life studies. His work often employs large cohort studies and combines clinical insights with robust epidemiological methods to address important questions in endocrine disorders.

Dr. Dal is particularly recognized for his contributions to acromegaly research, where he has led several large national cohort studies mapping disease incidence, treatment patterns, and prognosis. He has also pioneered research in transgender healthcare as co-founder of a large Danish cohort studying gender-affirming hormone therapy and its effects.

As an academic supervisor, Dr. Dal has guided PhD research in endocrinology, focusing on areas such as pituitary disorders and transgender healthcare. His collaborative approach extends to numerous national and international research partnerships across Europe.

Dr. Dal maintains active research teams focused on pituitary disorders and transgender healthcare, working closely with clinicians, researchers, and patient organizations to advance understanding and treatment of complex endocrine conditions.